Merete Lund Hetland

Merete Lund Hetland

Clinical Professor

Member of:

  • Internal Medicine: Rheumatology


  1. 2012
  2. Published

    Efficacy of different doses of Rituximab for the treatment of RA: Data from the CERERRA collaboration

    Chatzidionysiou, K., Lie, E., Nasonov, E., Lukina, G., Hetland, Merete Lund, Tarp, U., Ancuta, I., Pavelka, K., Nordström, D., Gabay, C., Canhao, H., Tomsic, M., Van Riel, P., Gomez-Reino, J., Kvien, T. & Van Vollenhoven, R., 2012, In: Annals of the Rheumatic Diseases. 71, 3 suppl., p. 62 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. Published

    Genome wide association analysis of pain reduction in rheumatoid arthritis patients treated with anti-TNF medication. Results of the DREAM and DANBIO registries.

    Coehnen, M. J. H., Mirkov, M. U., Scheffer, H., Krintel, S. B., Vermeulen, S. H., Johansen, Julia Sidenius, Kiewit, W., Van de Laar, M. A. F. J., Van Riel, P. L. C. M., Franke, B. & Hetland, Merete Lund, 2012, In: Arthritis & Rheumatism. 64, 10 suppl., p. S188 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Published

    Impact of tumour necrosis factor inhibitor treatment on hand bone loss in rheumatoid arthritis patients treated in clinical practice. Results from the nationwide Danish Danbio Registry.

    Ørnbjerg, L. M., Østergaard, M., Boyesen, P., Jensen, T. D., Thormann, A., Tarp, U., Bohme, W., Dencker, D., Lindegaard, H. M., Poulsen, U. E., Hansen, A., Ringsdal, V. S., Schlemmer, A., Graudal, N., Andersen, A., Espesen, J., Kollerup, G., Christensen, T. G., Pelck, R., Glintborg, B. & 4 others, gjc556, gjc556, Jensen, D. V., Majgaard, O. & Hetland, Merete Lund, 2012, In: Arthritis & Rheumatism. 64, 10 suppl., p. S156-7 2 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  5. Published

    Insulin-like growth factor I receptor density on CD4+T-lymphocytes from active early steroid- and DMARD-naïve rheumatoid arthritis patients is up-regulated and not influenced by 1 year of clinically effective treatment

    Laurberg, T. B., Ellingsen, T. J., Thorsen, J., Møller, B. K., Hansen, I. T., Tarp, U., Hetland, Merete Lund, Hørslev-Petersen, K., Flyvbjerg, A., Frystyk, J. & Stengaard-Pedersen, K., 2012, In: Rheumatology International. 32, 2, p. 501-4 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis

    Krintel, S. B., Palermo, G., Johansen, J. S., Germer, S., Essioux, L., Benayed, R., Badi, L., Østergaard, Mikkel & Hetland, Merete Lund, 2012, In: Pharmacogenetics and Genomics. 22, 8, p. 577-89 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    M-Ficolin, an activator of the complement system, predicts DAS28 remission in early DMARD naïve rheumatoid arthritis

    Ammitzbøll, C. G., Jensenius, J. C., Ellingsen, T., Thiel, S., Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Johansen, J., Østergaard, Mikkel, Pødenphanth, J., Stengaard-Pedersen, K. & the OPERA Study Group, T. O. S. G., 2012, In: Annals of the Rheumatic Diseases. 71, Suppl. 3, p. 131 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  8. Published

    M-ficolin, an activator of the complement system, is the strongest predictor of both DAS28 remission and low disease activity in a cohort of 180 early DMARD naïve rheumatoid arthritis patients followed in the Opera-study.

    Ammizbøll, C. G., Jensenius, J. C., Ellingsen, T., Thiel, S., Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Johansen, Julia Sidenius, Østergaard, Mikkel, Pødenphant, J. & Stengaard-Pedersen, K., 2012, In: Arthritis & Rheumatism. 64, 10, p. S1065 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  9. Published

    M-ficolin, an activator of the complement system, predicts DAS28 remission in early DMARD naïve rheumatoid arthritis.

    Ammizbøll, C. G., Jensenius, J. C., Ellingsen, T., Thiel, S., Hørslev-Petersen, K., Hetland, Merete Lund, Junker, P., Johansen, Julia Sidenius, Østergaard, Mikkel, Pødenphant, J., Stengaard-Pedersen, K. & OPERA study group, O. S. G., 2012, In: Scandinavian Journal of Rheumatology. Supplement. 41, 126 suppl., p. 24 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  10. Published

    MRI predicts development of rheumatoid arthritis in undifferentiated arthritis. Reply to comment by van der Helm-van Mil et al

    Duer-Jensen, A., Hørslev-Petersen, K., Hetland, Merete Lund, Bak, L., Ejbjerg, B. J., Hansen, M. S., Johansen, Julia Sidenius, Lindegaard, H. M., Vinterberg, H., Møller, J. M. & Østergaard, Mikkel, 2012, In: Arthritis & Rheumatism. 64, 1, p. 322-323 2 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Measuring outcomes in a busy practice

    Hetland, Merete Lund, 2012, In: Annals of the Rheumatic Diseases. 71, 3 suppl., p. 43 1 p.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

ID: 922207